White Paper
Expectation vs. Reality: Cost and Time to Bring SaMD to Market
Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.
Read Now
Biopharma and medtech companies trust BrightInsight’s compliant platform to differentiate and expand the value of their therapies with groundbreaking digital solutions. SaMD is the backbone of next-generation companion apps, dosing and treatment selection algorithms, data analytics and more. Learn how SaMD is transforming healthcare.
Digital enables more engaging patient experiences by increasing therapy compliance, improving disease and medical tracking and as importantly, building connections among patients and with healthcare providers. The data collected with digital can be used to deliver more personalized therapies, increase reimbursement and potentially increase revenues through extended patent life.
Brad Gescheider
Former Global Head, Digital Innovation and Patient Services, Immunology at Sanofi
Insights from top digital health executives on how to speed time to market and lower costs for SaMD solutions.
Read Now
While the potential applications for SaMD are myriad, a recent survey found that disease management was the most promising use case.
Read Infographic
This new guidance from the FDA has important information for anyone operating in the digital health space.
Learn More
Contact us today to start a conversation about how BrightInsight can help on your digital health journey.
Contact us
